Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

The Cooper Companies, Inc. (COO) vs West Pharmaceutical Services, Inc. (WST)

The Cooper Companies, Inc. and West Pharmaceutical Services, Inc. are both Medical Instruments & Supplies companies. West Pharmaceutical Services, Inc. is the larger, with a market value of $26.3B against $10.5B — 2.5× the size. The Cooper Companies, Inc. trades at the lower P/E: 18.9× against 47.1×. West Pharmaceutical Services, Inc. grew revenue faster over the last twelve months: 12.4% against 4.73%. West Pharmaceutical Services, Inc. has the higher net margin (17.0% vs 13.5%) and the higher return on invested capital (15.4% vs 3.17%). Only West Pharmaceutical Services, Inc. pays a dividend (0.14%). Across the 23 metrics below, The Cooper Companies, Inc. leads on 12 and West Pharmaceutical Services, Inc. on 11.

Valuation

Metric COO WST Medical Instruments & Supplies median
P/E 18.90 47.07 34.17
P/S 2.52 7.88 2.83
P/B 1.28 8.77 2.82
Price to free cash flow 15.76 60.56 25.69
EV/EBITDA 14.09 30.16 16.08
EV/Sales 3.09 7.81 3.06
Earnings yield 5.29% 2.12% (1.84%)
Free cash flow yield 6.34% 1.65% 0.17%

Profitability

Metric COO WST Medical Instruments & Supplies median
Gross margin 65.93% 36.79% 54.62%
Operating margin 12.84% 20.45% 1.64%
Net margin 13.46% 16.98% 0.00%
Free cash flow margin 16.00% 13.13% 1.61%
Return on equity 6.84% 19.09% 0.00%
Return on assets 4.55% 14.07% 0.00%
Return on invested capital 3.17% 15.42% 0.00%

Growth

Metric COO WST Medical Instruments & Supplies median
Revenue growth (TTM) 4.73% 12.38% 9.20%
EPS growth (last fiscal year) (4.59%) 1.49% —
Revenue growth, 5-year CAGR 10.98% 7.44% 9.48%
Net income growth, 5-year CAGR 9.48% 7.36% 0.00%

Health

Metric COO WST Medical Instruments & Supplies median
Debt to equity 0.31 0.07 0.08
Current ratio 1.22 2.82 2.49
Net debt to EBITDA 2.26 (0.78) 0.83

Dividend

Metric COO WST Medical Instruments & Supplies median
Dividend yield 0.00% 0.14% 0.99%
Payout ratio 0.01 0.11 0.00

Size

Metric COO WST Medical Instruments & Supplies median
Market cap 10.48b 26.29b 938.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack